Enhancing the Hepatitis C Cascade of Care: Implementation Science Approach in a Federally Qualified Health Center System
Authors:
- Itamar HarariIHItamar Harari
- Adrienne Martinez HollingsworthAHAdrienne Martinez Hollingsworth
- Tracey BlancoTBTracey Blanco
- Zurisadai InzunzaZIZurisadai Inzunza
- Adriana Lopez VasquezAVAdriana Lopez Vasquez
- Monika SchererMSMonika Scherer
- Namrata ShivaprakashNSNamrata Shivaprakash
- Juan Pablo CaeiroJuan Pablo Caeiro
Open Access
- 23 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
Abstract
Context: Hepatitis C virus (HCV) remains a significant public health challenge in the United States, particularly among underserved populations. Despite curative treatments, systemic barriers often delay the care cascade. Program: This quality improvement program aimed at improving the care of patients with chronic Hepatitis C within a Federally Qualified Health Center system in Southern California, known as AltaMed Health Services. The program involves AltaMed, serving more than 700 000 patients, primarily low-income people in underserved communities through an integrated delivery system for Latino and multiethnic individuals, focusing on enhancing screening and treatment processes for Hepatitis C. Methods: A multipronged clinical workflow redesign was evaluated utilizing the RE-AIM framework to assess process and clinical between 2022 and 2024. Intervention included an electronic health record (EHR) Best Practice Advisory to identify patients due for HCV screening, a standardized direct-referral workflow, and a Linkage to Care team to manage prior authorization administrative tasks and patient outreach efforts. Evaluation: Total descriptive HCV screening volumes increased from 30 212 to 47 951, with screening rates expanding from 3.4% to 7.3% in nonspecialty clinics. Treatment initiation rates shifted from 36% to 45%, and post-treatment patient outreach documentation changed from 48% to 73%. The average duration from diagnosis to treatment initiation was observed to be 55.9% lower, changing from 34 weeks in 2022 and 15 weeks in 2024. Discussion: Establishing an Linkage to Care team, combined with automated EHR tools, can track alongside meaningful improvements in the safety-net HCV care cascade. Scaling models require careful consideration of specialized staffing and localized EHR infrastructure to advance health equity and global HCV elimination goals.Keywords
This publication has 14 references indexed in Scilit:
- A Road Map to Hepatitis C Elimination: Yesterday, Today, and TomorrowOpen Forum Infectious Diseases, 2024
- An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of BaltimoreOpen Forum Infectious Diseases, 2024
- 1071. Social Determinants of health (SDOH) among PWID living with HCVOpen Forum Infectious Diseases, 2020
- Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection RiskJournal of Urban Health, 2020
- Implementation science: What is it and why should I care?Psychiatry Research, 2020
- Global Elimination of Chronic HepatitisNew England Journal of Medicine, 2019
- Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016Hepatology, 2018
- Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agentsAlimentary Pharmacology & Therapeutics, 2017
- Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antiviralsHepatology, 2016
- Bridging the Gap Between Research and Practice: Implementation ScienceJournal of Speech, Language, and Hearing Research, 2015